Activity and tolerability of nilotinib
Activity and tolerability of nilotinib
复制标题
尼洛替尼的活性和耐受性
作者：
M. Koren;P. le Coutre;J. Duyster;C. Scheid;P. Panayiotidis;W. Prejzner;J. Rowe;M. Schwarz;N. Goldschmidt;A. Nagler
尼洛替尼对伊马替尼耐药和不耐受的慢性粒细胞白血病患者有活性，最近被批准用于这些适应症。
Nilotinib is active in imatinib‐resistant and ‐intolerant chronic myeloid leukemia patients and was recently approved for these indications.
影响因子：
50.3
作者：
Weisberg, E;Manley, PW;Griffin, JD
通讯作者：
Griffin, JD